TissueGUARD

We are pleased to announce that TissueGUARD's leadership team will present our latest developments in ophthalmic medical devices and regenerative biotechnologies at the World Eye Bank Symposium (WEBS 2026) in Prague on 25 June 2026.
Simone Arndt, M.Sc. will present our novel DSAEK devices and graft preparation technology, while Mikhail Tsurkan, PhD, will present our work on regenerative medicine approaches using bioengineered Descemet membranes for corneal endothelial replacement.
These scientific presentations highlight our ongoing efforts to advance corneal transplantation through innovative research and technology development. We look forward to engaging with colleagues from the global eye banking, corneal surgery, and ophthalmology communities at WEBS 2026.

TissueGUARD is committed to advancing corneal transplantation through innovative device solutions. Visit us at EBAA 2026 to explore our latest developments in DMEK and DSAEK tissue preparation and delivery. We look forward to presenting our innovations to eye banks and corneal surgeons.

We will be attending Medtec Japan in Tokyo from 21–23 April and are currently seeking partners for our ophthalmic surgical devices.
During the same week, thanks to Start2 Group and German Accelerator, we will also participate in the SusHi Tech Tokyo 2026 exhibition on April 27-29, where we will present our latest developments in innovative hydrogel-based medical technologies.
If you are a medtech partner in Japan, connect with us to explore potential collaboration and business opportunities.

TissueGUARD will be exhibiting at EEBA 2026 in A Coruña, Spain (19–21 March).
We will present our DMEK keratoplasty device, currently in CE certification, and introduce our latest DSAEK injector development, enabling graft injection using a technique similar to DMEK. Its manufacturing was supported by the European Union and Sächsische Aufbaubank - Förderbank - co-funding.
If you are attending EEBA, feel free to stop by our booth.

Great to see the TissueGUARD DMEK Injector featured in a recently published corneal transplantation video on YouTube.
The video, shared on Dr. James Tian's YouTube channel, shows the injector in use during a DMEK procedure. The graft shown was prepared by RMLEB.
🎥 Video link: https://www.youtube.com/watch?v=_iACg-xt3tY
Thank you, Dr. James Tian and Rocky Mountain Lions Eye Bank, for using our devices.

As the year draws to a close and the holiday season approaches, we are celebrating five years since Mikhail, Sarah, and Simone became a team at TissueGUARD. Moving from a research spin-off to a fully operational FDA-registered company with several products on the market in just five years was an impressive journey with its ups and downs.
We are entering the new year with big goals, including European CE certification and a major expansion of our portfolio. A Big Thank you to our incredible personnel, contractors, friends, and supporters. We couldn’t have done this without you.
Wishing you all a Merry Christmas and a wonderful holiday season!

International Women’s Day! We wish all women worldwide a successful and fulfilling journey. At TissueGUARD, we especially celebrate the incredible women driving innovation in medicine, medical technology, and patient care.

TissueGUARD is proud to exhibit at the 2025 Pittsburgh Cornea Symposium hosted by the Center for Organ Recovery & Education CORE! Join us at our booth to explore our solutions for DMEK and DSAEK applications. Don’t miss the chance to see our innovative devices and connect with our team. We look forward to seeing you there!

Not registered yet? Secure your spot here: https://core.org/professionals/eye-bank/2025-pittsburgh-cornea-symposium/

During our visit to Philadelphia, we had a great opportunity to visit AltruVision. We presented our TissueGUARD devices for Keratoplasty and shared insights on their benefits for corneal transplantation. It was inspiring to see AltruVision's dedication to advancing eye banking and patient care. Thank you to Gregory Dorn for hosting us at the eye bank and giving us a tour of the facilities. Looking forward to future collaborations!

We’re excited to exhibit once again at the Advanced Therapies USA conference, this time in Philadelphia!
Beyond our work in innovative medical devices for ophthalmology, TissueGUARD is developing advanced substitution therapies for diseases affecting the cornea, retina, and ischemia. Visit us at Stand 9 in the Startup Zone on November 12-13 to discover our technologies for tissue formation, organoid development, and next-generation cell therapies in regenerative medicine for ophthalmology (cornea, retina) and ischemia (stroke).
Looking forward to connecting with you there!